// App-Quantinova.ai

5595 : Immune profile and outcomes of patients (pts) with gynecological malignancies (GYN) enrolled in early phases immunotherapy (IO) trials.

Researchers

Presenter

  • Victor Rodriguez Freixinos

Principal Investigators

  • Angel Garcia

  • Roberta Fasani

  • Josep Castellvi

  • Fiorella Ruiz-Pace

  • Cristina Viaplana

  • Lorena Farinas-Madrid

  • Cristina Casal

  • Ignacio Matos

  • Juan Martin-Liberal

  • Irene Brana

  • Cinta Hierro

  • Jose Jimenez

  • Elena Garralda

  • Paolo Nuciforo

  • Rodrigo Dienstmann

  • Ana Oaknin

Medical Centers

  • Vall d'Hebron University Hospital, Barcelona, Spain

  • Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain

  • Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

  • Oncology Data Science (OdySsey) Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

  • Vall dHebron University Hospital Institute of Oncology, Barcelona, Spain

  • Vall d'Hebron University Hospital, Barcelona, Spain

  • Vall d'Hebron Institute of Oncology, Barcelona, Spain

  • Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain and Catalan Institute of Oncology (ICO) Hospitalet, Barcelona, Spain

  • Molecular Therapeutics Research Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

  • Pathology Department, Vall d'Hebron University Hospital, Barcelona, Spain

  • Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

  • Oncology Data Science (OdySsey) Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

  • Vall d'Hebron Institute of Oncology, Barcelona, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Neutrophil lymphocyte ratio

  • Programmed death-ligand 1

  • Lactate dehydrogenase

  • tumor-infiltrating lymphocytes

  • Microsatellite instability

Drug/Treatment

  • SP263

Outcome

  • N/A


Study Design

  • N/A

Phase

  • I/II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final